Jan Markus Grimm

Directeur/Membre du Conseil chez

AL-S Pharma AG

Commercial Services

Health Technology

Profil

Jan Markus Grimm has worked as a Director at Neurimmune Holding AG since 2020 and is currently employed there.
He has also worked as a Director at AL-S Pharma AG and NovaGo Therapeutics AG, but it is unclear if he is still employed at those companies.

Postes actifs de Jan Markus Grimm

Sociétés	Poste	Début
AL-S Pharma AG AL-S Pharma AG Miscellaneous Commercial ServicesCommercial Services Provides drug discovery, translational research and clinical development services	Directeur/Membre du Conseil	-
NovaGo Therapeutics AG NovaGo Therapeutics AG Pharmaceuticals: MajorHealth Technology Develops and manufactures human antibody therapeutic products	Directeur/Membre du Conseil	-
Neurimmune Holding AG Neurimmune Holding AG Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company that builds generation antibody therapeutics	Directeur/Membre du Conseil	03/02/2020

Tous les postes actifs de Jan Markus Grimm

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Jan Markus Grimm

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	3
Neurimmune Holding AG Neurimmune Holding AG Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company that builds generation antibody therapeutics	Commercial Services
AL-S Pharma AG AL-S Pharma AG Miscellaneous Commercial ServicesCommercial Services Provides drug discovery, translational research and clinical development services	Commercial Services
NovaGo Therapeutics AG NovaGo Therapeutics AG Pharmaceuticals: MajorHealth Technology Develops and manufactures human antibody therapeutic products	Health Technology